The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Smoking Cessation Aids-Global Market Insights and Sales Trends 2024
Synopsis
Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking.
The global Smoking Cessation Aids market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Smoking Cessation Aids in various end use industries. The expanding demands from the Pharmacy, Supermarket, Hospital and Other, are propelling Smoking Cessation Aids market. NRT Inhaler, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NRT Patch segment is estimated at % CAGR for the next seven-year period.
Amongst NRT products, NRT Gums has the largest share in the market. Amongst prescription products, inhalers, and sprays have the largest market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Smoking Cessation Aids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Smoking Cessation Aids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Smoking Cessation Aids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Smoking Cessation Aids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Smoking Cessation Aids covered in this report include Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis, Johnson and Johnson, Bayer, Cipla and Takeda Pharmaceuticals, etc.
The global Smoking Cessation Aids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Reckitt Benckiser
Pfizer
GlaxoSmithKline
Roche
Novartis
Johnson and Johnson
Bayer
Cipla
Takeda Pharmaceuticals
NJOY
Global Smoking Cessation Aids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Smoking Cessation Aids market, Segment by Type:
NRT Inhaler
NRT Patch
Spray
Drug
Electronic Cigarettes
Other
Global Smoking Cessation Aids market, by Application
Pharmacy
Supermarket
Hospital
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Smoking Cessation Aids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Smoking Cessation Aids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking.
The global Smoking Cessation Aids market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Smoking Cessation Aids in various end use industries. The expanding demands from the Pharmacy, Supermarket, Hospital and Other, are propelling Smoking Cessation Aids market. NRT Inhaler, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the NRT Patch segment is estimated at % CAGR for the next seven-year period.
Amongst NRT products, NRT Gums has the largest share in the market. Amongst prescription products, inhalers, and sprays have the largest market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Smoking Cessation Aids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Smoking Cessation Aids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Smoking Cessation Aids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Smoking Cessation Aids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Smoking Cessation Aids covered in this report include Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis, Johnson and Johnson, Bayer, Cipla and Takeda Pharmaceuticals, etc.
The global Smoking Cessation Aids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Reckitt Benckiser
Pfizer
GlaxoSmithKline
Roche
Novartis
Johnson and Johnson
Bayer
Cipla
Takeda Pharmaceuticals
NJOY
Global Smoking Cessation Aids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Smoking Cessation Aids market, Segment by Type:
NRT Inhaler
NRT Patch
Spray
Drug
Electronic Cigarettes
Other
Global Smoking Cessation Aids market, by Application
Pharmacy
Supermarket
Hospital
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Smoking Cessation Aids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Smoking Cessation Aids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Smoking Cessation Aids Market Overview
1.1 Smoking Cessation Aids Product Overview
1.2 Smoking Cessation Aids Market Segment by Type
1.2.1 NRT Inhaler
1.2.2 NRT Patch
1.2.3 Spray
1.2.4 Drug
1.2.5 Electronic Cigarettes
1.2.6 Other
1.3 Global Smoking Cessation Aids Market Size by Type
1.3.1 Global Smoking Cessation Aids Market Size Overview by Type (2018-2029)
1.3.2 Global Smoking Cessation Aids Historic Market Size Review by Type (2018-2023)
1.3.3 Global Smoking Cessation Aids Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Smoking Cessation Aids Sales Breakdown by Type (2018-2023)
1.4.2 Europe Smoking Cessation Aids Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Smoking Cessation Aids Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Smoking Cessation Aids Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Smoking Cessation Aids Sales Breakdown by Type (2018-2023)
2 Global Smoking Cessation Aids Market Competition by Company
2.1 Global Top Players by Smoking Cessation Aids Sales (2018-2023)
2.2 Global Top Players by Smoking Cessation Aids Revenue (2018-2023)
2.3 Global Top Players by Smoking Cessation Aids Price (2018-2023)
2.4 Global Top Manufacturers Smoking Cessation Aids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Smoking Cessation Aids Market Competitive Situation and Trends
2.5.1 Smoking Cessation Aids Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Smoking Cessation Aids Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Smoking Cessation Aids as of 2022)
2.7 Date of Key Manufacturers Enter into Smoking Cessation Aids Market
2.8 Key Manufacturers Smoking Cessation Aids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Smoking Cessation Aids Status and Outlook by Region
3.1 Global Smoking Cessation Aids Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Smoking Cessation Aids Historic Market Size by Region
3.2.1 Global Smoking Cessation Aids Sales in Volume by Region (2018-2023)
3.2.2 Global Smoking Cessation Aids Sales in Value by Region (2018-2023)
3.2.3 Global Smoking Cessation Aids Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Smoking Cessation Aids Forecasted Market Size by Region
3.3.1 Global Smoking Cessation Aids Sales in Volume by Region (2024-2029)
3.3.2 Global Smoking Cessation Aids Sales in Value by Region (2024-2029)
3.3.3 Global Smoking Cessation Aids Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Smoking Cessation Aids by Application
4.1 Smoking Cessation Aids Market Segment by Application
4.1.1 Pharmacy
4.1.2 Supermarket
4.1.3 Hospital
4.1.4 Other
4.2 Global Smoking Cessation Aids Market Size by Application
4.2.1 Global Smoking Cessation Aids Market Size Overview by Application (2018-2029)
4.2.2 Global Smoking Cessation Aids Historic Market Size Review by Application (2018-2023)
4.2.3 Global Smoking Cessation Aids Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Smoking Cessation Aids Sales Breakdown by Application (2018-2023)
4.3.2 Europe Smoking Cessation Aids Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Smoking Cessation Aids Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Smoking Cessation Aids Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Smoking Cessation Aids Sales Breakdown by Application (2018-2023)
5 North America Smoking Cessation Aids by Country
5.1 North America Smoking Cessation Aids Historic Market Size by Country
5.1.1 North America Smoking Cessation Aids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Smoking Cessation Aids Sales in Volume by Country (2018-2023)
5.1.3 North America Smoking Cessation Aids Sales in Value by Country (2018-2023)
5.2 North America Smoking Cessation Aids Forecasted Market Size by Country
5.2.1 North America Smoking Cessation Aids Sales in Volume by Country (2024-2029)
5.2.2 North America Smoking Cessation Aids Sales in Value by Country (2024-2029)
6 Europe Smoking Cessation Aids by Country
6.1 Europe Smoking Cessation Aids Historic Market Size by Country
6.1.1 Europe Smoking Cessation Aids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Smoking Cessation Aids Sales in Volume by Country (2018-2023)
6.1.3 Europe Smoking Cessation Aids Sales in Value by Country (2018-2023)
6.2 Europe Smoking Cessation Aids Forecasted Market Size by Country
6.2.1 Europe Smoking Cessation Aids Sales in Volume by Country (2024-2029)
6.2.2 Europe Smoking Cessation Aids Sales in Value by Country (2024-2029)
7 Asia-Pacific Smoking Cessation Aids by Region
7.1 Asia-Pacific Smoking Cessation Aids Historic Market Size by Region
7.1.1 Asia-Pacific Smoking Cessation Aids Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Smoking Cessation Aids Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Smoking Cessation Aids Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Smoking Cessation Aids Forecasted Market Size by Region
7.2.1 Asia-Pacific Smoking Cessation Aids Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Smoking Cessation Aids Sales in Value by Region (2024-2029)
8 Latin America Smoking Cessation Aids by Country
8.1 Latin America Smoking Cessation Aids Historic Market Size by Country
8.1.1 Latin America Smoking Cessation Aids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Smoking Cessation Aids Sales in Volume by Country (2018-2023)
8.1.3 Latin America Smoking Cessation Aids Sales in Value by Country (2018-2023)
8.2 Latin America Smoking Cessation Aids Forecasted Market Size by Country
8.2.1 Latin America Smoking Cessation Aids Sales in Volume by Country (2024-2029)
8.2.2 Latin America Smoking Cessation Aids Sales in Value by Country (2024-2029)
9 Middle East and Africa Smoking Cessation Aids by Country
9.1 Middle East and Africa Smoking Cessation Aids Historic Market Size by Country
9.1.1 Middle East and Africa Smoking Cessation Aids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Smoking Cessation Aids Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Smoking Cessation Aids Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Smoking Cessation Aids Forecasted Market Size by Country
9.2.1 Middle East and Africa Smoking Cessation Aids Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Smoking Cessation Aids Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Reckitt Benckiser
10.1.1 Reckitt Benckiser Company Information
10.1.2 Reckitt Benckiser Introduction and Business Overview
10.1.3 Reckitt Benckiser Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Reckitt Benckiser Smoking Cessation Aids Products Offered
10.1.5 Reckitt Benckiser Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Smoking Cessation Aids Products Offered
10.2.5 Pfizer Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Smoking Cessation Aids Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Smoking Cessation Aids Products Offered
10.4.5 Roche Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis Smoking Cessation Aids Products Offered
10.5.5 Novartis Recent Development
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Company Information
10.6.2 Johnson and Johnson Introduction and Business Overview
10.6.3 Johnson and Johnson Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson and Johnson Smoking Cessation Aids Products Offered
10.6.5 Johnson and Johnson Recent Development
10.7 Bayer
10.7.1 Bayer Company Information
10.7.2 Bayer Introduction and Business Overview
10.7.3 Bayer Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bayer Smoking Cessation Aids Products Offered
10.7.5 Bayer Recent Development
10.8 Cipla
10.8.1 Cipla Company Information
10.8.2 Cipla Introduction and Business Overview
10.8.3 Cipla Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cipla Smoking Cessation Aids Products Offered
10.8.5 Cipla Recent Development
10.9 Takeda Pharmaceuticals
10.9.1 Takeda Pharmaceuticals Company Information
10.9.2 Takeda Pharmaceuticals Introduction and Business Overview
10.9.3 Takeda Pharmaceuticals Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Takeda Pharmaceuticals Smoking Cessation Aids Products Offered
10.9.5 Takeda Pharmaceuticals Recent Development
10.10 NJOY
10.10.1 NJOY Company Information
10.10.2 NJOY Introduction and Business Overview
10.10.3 NJOY Smoking Cessation Aids Sales, Revenue and Gross Margin (2018-2023)
10.10.4 NJOY Smoking Cessation Aids Products Offered
10.10.5 NJOY Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Smoking Cessation Aids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Smoking Cessation Aids Industrial Chain Analysis
11.4 Smoking Cessation Aids Market Dynamics
11.4.1 Smoking Cessation Aids Industry Trends
11.4.2 Smoking Cessation Aids Market Drivers
11.4.3 Smoking Cessation Aids Market Challenges
11.4.4 Smoking Cessation Aids Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Smoking Cessation Aids Distributors
12.3 Smoking Cessation Aids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
